Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00352313
What this trial is testing

ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC) 82
Testing effectiveness (Phase 2)Study completedNCT00717197
What this trial is testing

Study of Capecitabine to Treat Recurrent High Grade Gliomas

Who this might be right for
Malignant Glioma
University of Florida 30
Very early researchStudy completedNCT04937413
What this trial is testing

The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation

Who this might be right for
Malignant GliomaGlioblastoma
Duke University 32
Early research (Phase 1)Ended earlyNCT05627323
What this trial is testing

CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
Chimeric Therapeutics 1
Not applicableStudy completedNCT03626896
What this trial is testing

Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients

Who this might be right for
Glioblastoma MultiformeBrain TumorGlioblastoma+3 more
NaviFUS Corporation 6
Testing effectiveness (Phase 2)Study completedNCT00615927
What this trial is testing

Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 64
Testing effectiveness (Phase 2)Study completedNCT02343224
What this trial is testing

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

Who this might be right for
Juvenile Pilocytic AstrocytomasOptic Pathway Gliomas
Emory University 9
Not applicableStudy completedNCT02060890
What this trial is testing

Molecular Profiling in Guiding Individualized Treatment Plan in Adults With Recurrent/Progressive Glioblastoma

Who this might be right for
Adult Glioblastoma
University of California, San Francisco 20
Early research (Phase 1)Ended earlyNCT01122888
What this trial is testing

Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+2 more
National Cancer Institute (NCI) 41
Early research (Phase 1)Ended earlyNCT02648633
What this trial is testing

Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
University of Virginia 4
Testing effectiveness (Phase 2)Study completedNCT00070525
What this trial is testing

Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma

Who this might be right for
Childhood High-grade Cerebral AstrocytomaChildhood OligodendrogliomaRecurrent Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 90
Early research (Phase 1)Active Not RecruitingNCT04606316
What this trial is testing

Surgical Nivolumab And Ipilimumab For Recurrent GBM

Who this might be right for
GlioblastomaGBMGlioblastoma Multiforme+1 more
Patrick Wen, MD 63
Early research (Phase 1)UnknownNCT00002647
What this trial is testing

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Medical College of Wisconsin 24
Testing effectiveness (Phase 2)Ended earlyNCT01582152
What this trial is testing

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma

Who this might be right for
Brain NeoplasmsCentral Nervous System Neoplasms
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT02986178
What this trial is testing

Lerapolturev in Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Istari Oncology, Inc. 121
Early research (Phase 1)Study completedNCT01975116
What this trial is testing

P28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Who this might be right for
Teratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more
Pediatric Brain Tumor Consortium 18
Testing effectiveness (Phase 2)Study completedNCT01564914
What this trial is testing

Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Tracon Pharmaceuticals Inc. 22
Testing effectiveness (Phase 2)Ended earlyNCT01310855
What this trial is testing

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Glioblastoma
University College, London 38
Testing effectiveness (Phase 2)Looking for participantsNCT06220552
What this trial is testing

The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Fifth Affiliated Hospital, Sun Yat-Sen University 20
Early research (Phase 1)Looking for participantsNCT04573140
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

Who this might be right for
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
University of Florida 28
Next Page